BETASTEM THERAPEUTICS INC
Grant: $326,697 - National Institutes of Health - Sep. 30, 2009
No votes have been cast for this award yet
Join the conversation: Post a comment about this award
Award Description: The long term goal is to develop an efficient, safe clinical treatment for diabetic retinopathy using stem cells from the patient's bone marrow or blood that have been activated to repair damaged vessels in the eye. Diabetic retinopathy remains theleading cause of ireversible blindness among working-age adults. If these stem cells are treated temporarily with a drug that blocks an important regulator of stem cell activation (i.e., transforming growth factor-beta) vessel repair is greatly enhanced. We plan to test the repair capacity of stem cells obtained from diabetic patients to those from non-diabetic patients.
Project Description: No significant activity
Jobs Summary: None (Total jobs reported: 0)
Project Status: Not Started
This award's data was last updated on Sep. 30, 2009. Help expand these official descriptions using the wiki below.
No comments have been added for this project.